Seer Inc (NAS:SEER)
$ 2.47 -0.03 (-1.2%) Market Cap: 145.65 Mil Enterprise Value: -75.45 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 56/100

Seer Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 04:30PM GMT
Release Date Price: $42.2 (-1.29%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey, everyone. Thanks for joining us today on day 1 of our Health Care Conference. I'm Tejas Savant, and I cover the Life Science Tools and Diagnostics Space here at Morgan Stanley.

I'm delighted to have Seer joined us this morning. And representing the company are Omid Farokhzad, CEO; David Horn, CFO; and Omead Ostadan, President and COO.

Before we get into the discussion, just a quick safe harbor here. For important disclosures, please see Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales rep.

So with that, Omid, maybe we'll just start with a quick overview of Seer for those who are new to the story, and then we'll dig into the details.

Omid C. Farokhzad
Seer, Inc. - Founder, CEO & Chair of the Board of Directors

Okay. Thanks, Tejas. Good morning, everyone. Thanks so

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot